SC 13G/A: Galera Therapeutics, Inc.

Ticker: GRTX · Form: SC 13G/A · Filed: May 16, 2024 · CIK: 1563577

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Galera Therapeutics, Inc..

Risk Assessment

Risk Level: low

Filing Stats: 754 words · 3 min read · ~3 pages · Grade level 10.2 · Accepted 2024-05-16 10:26:17

Key Financial Figures

Filing Documents

(a)

ITEM 1 (a) NAME OF ISSUER: Galera Therapeutics Inc.

(b)

ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 45 Liberty Blvd., Suite 230, Malvern, Pennsylvania 19355

(a)

ITEM 2 (a) NAME OF PERSON FILING: Yair Schneid

(b)

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 1 Wood Lane, Suffern, NY 10901

(c)

ITEM 2 (c) CITIZENSHIP: USA

(d)

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Shares, $0.001 par value per share

(e)

ITEM 2 (e) CUSIP NUMBER: 36338D108

IF

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

OWNERSHIP

ITEM 4 OWNERSHIP (a) AMOUNT BENEFICIALLY OWNED: 10,823,610 Shares (1)(2) (b) PERCENT OF CLASS: 19.90% (1)(2) (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) SOLE POWER TO VOTE OR DIRECT THE VOTE 10,823,610 Shares (1)(2) (ii) SHARED POWER TO VOTE OR DIRECT THE VOTE 0 Shares (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 10,823,610 Shares (1)(2) (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 0 Shares CUSIP No. 36338D108 13G/A Page 4 of 5 Pages

OWNERSHIP

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable

OWNERSHIP

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable

IDENTIFICATION

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP Not applicable

NOTICE

ITEM 9 NOTICE OF DISSOLUTION OF GROUP Not applicable CUSIP No. 36338D108 13G/A Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. May 15, 2024 (Date) /s/ Yair Schneid (Signature) Yair Schneid (Name/Title)

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing